Inventor

Thomas Frenzel

Inventor
Berlin, DE

Overview

30→
Patents
1998–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 30 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07DHeterocyclic compounds19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C07CAcyclic or carbocyclic compounds14%
C07KPeptides8%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
C07JSteroids5%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers3%
B82YSpecific uses or applications of nanostructures1%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds1%
PatentTitleYear
10,975,060High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging202110,722,601Gadolinium chelate compounds for use in magnetic resonance imaging202010,137,209Gadolinium chelate compounds for use in magnetic resonance imaging20189,034,856'17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative'20158,987,239'19-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives'20158,937,058'17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative'20158,623,850'15, 16-methylene-17-(1′-propenyl)-17,3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative'20148,207,150'17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative'20127,226,578'Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis'20077,211,241'Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes'20077,164,016'Macrocyclic metal complexes and their use for the production of conjugates with biomolecules'20076,916,461'Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis'20056,861,043'Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes'20056,468,502'Metal complexes that contain perfluoroalkly, process for their production and their use in NMR diagnosis'20026,461,587'Perfluoroalkylamides, their production and their use in diagnosis'20026,426,059'Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes'20026,248,306'Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes'20016,180,113'Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes'20016,177,060'Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes'20016,166,200'Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes'20006,136,841'3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical agents that contain the latter, process for their production and their use in photodynamic therapy and MRI diagnosis'20006,114,321'Porphyrin derivatives, pharmaceutical agents that contain the latter, and their use in photodynamic therapy and MRI diagnosis'20006,063,361'Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes'20006,057,419'Cascade polymer complexes, process for producing the same and pharmaceuticals containing the same'20006,019,959'Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis'20005,876,698'Macrocyclic polymer complexing agents, their complexes, process for their production and pharmaceutical agents containing these compounds'19995,874,061'Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes'19995,820,849'Cascade polymer complexes, process for their production and pharamceutical agents containing said complexes'19985,759,518'Metal complexes of dendrimeric macromolecules, diagnostics agents that contain the latter as well as process for the production of the complexes and agents'19985,733,522'Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use and process for their production'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2007Patents assigned to SCHERING AG (20)· patent assignee history
1998–2021Based in Berlin, DE· patent location history
2012–2015Patents assigned to BOHLMANN ROLF (4)· patent assignee history
2012–2015Patents assigned to BORDEN STEFFEN (4)· patent assignee history
2012–2021Patents assigned to Bayer Pharma AG (4)· patent assignee history
2012–2015Patents assigned to FRENZEL THOMAS (4)· patent assignee history
2012–2015Based in Hofheim, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SCHERING AG201998–2007
BOHLMANN ROLF42012–2015
BORDEN STEFFEN42012–2015
Bayer Pharma AG42012–2021
FRENZEL THOMASself42012–2015
Locations
LocationPatentsSpan
Berlin, DE251998–2021
Hofheim, DE52012–2015